Quipt Home Medical Responds to Kanen Wealth Management

Core Viewpoint - Quipt Home Medical Corp. is facing a proxy solicitation from Philotimo Fund, LP, which is affiliated with Kanen Wealth Management, to support four director candidates in opposition to the Company's nominees for the Board of Directors [1][9]. Group 1: Company Strategy and Governance - The Company is committed to delivering long-term value to shareholders and will review KWM's notice in accordance with its governance procedures [2][3]. - The Lead Independent Director emphasized the Company's focus on executing its strategic growth plan and maintaining high corporate governance standards, despite challenges in the industry [3]. - The Company engages regularly with shareholders to gather feedback aimed at enhancing performance and maintaining open communication [3]. Group 2: Proxy Solicitation Details - The Company has not yet received a valid notice for nominating directors as per U.S. securities laws and its Articles, and shareholders are not required to take any action at this time [4][9]. - A Management Information and Proxy Circular was filed with the SEC on January 24, 2025, in connection with the solicitation of proxies for the upcoming annual general meeting scheduled for March 17, 2025 [8]. - KWM must comply with both SEC rules and the Company's Advance Notice Policy to nominate candidates for the Board [9]. Group 3: Business Overview - Quipt Home Medical provides in-home monitoring and disease management services, focusing on respiratory solutions and chronic disease management for patients in the U.S. healthcare market [5]. - The Company's primary objective is to create shareholder value by expanding its service offerings and increasing annual revenue per patient through consolidated services [5].